Works matching IS 00070920 AND DT 2024 AND VI 130 AND IP 2
Results: 17
Stromal localization of inactive CD8<sup>+</sup> T cells in metastatic mismatch repair deficient colorectal cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 213, doi. 10.1038/s41416-023-02500-x
- By:
- Publication type:
- Article
Progress of immune checkpoint inhibitors therapy for non-small cell lung cancer with liver metastases.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 165, doi. 10.1038/s41416-023-02482-w
- By:
- Publication type:
- Article
Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 308, doi. 10.1038/s41416-023-02526-1
- By:
- Publication type:
- Article
Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 201, doi. 10.1038/s41416-023-02510-9
- By:
- Publication type:
- Article
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 317, doi. 10.1038/s41416-023-02511-8
- By:
- Publication type:
- Article
EEF1A2 promotes HIF1A mediated breast cancer angiogenesis in normoxia and participates in a positive feedback loop with HIF1A in hypoxia.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 184, doi. 10.1038/s41416-023-02509-2
- By:
- Publication type:
- Article
Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 327, doi. 10.1038/s41416-023-02508-3
- By:
- Publication type:
- Article
Treatment interval in curative treatment of colon cancer, does it impact (cancer free) survival? A non-inferiority analysis.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 251, doi. 10.1038/s41416-023-02505-6
- By:
- Publication type:
- Article
The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 297, doi. 10.1038/s41416-023-02507-4
- By:
- Publication type:
- Article
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 269, doi. 10.1038/s41416-023-02503-8
- By:
- Publication type:
- Article
Health benefits and harms of mammography screening in older women (75+ years)—a systematic review.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 275, doi. 10.1038/s41416-023-02504-7
- By:
- Publication type:
- Article
Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 242, doi. 10.1038/s41416-023-02501-w
- By:
- Publication type:
- Article
Body composition and cancer survival: a narrative review.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 176, doi. 10.1038/s41416-023-02470-0
- By:
- Publication type:
- Article
Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 260, doi. 10.1038/s41416-023-02499-1
- By:
- Publication type:
- Article
Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 336, doi. 10.1038/s41416-023-02498-2
- By:
- Publication type:
- Article
Efficacy and quality of life for FOLFOX/bevacizumab +/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 233, doi. 10.1038/s41416-023-02496-4
- By:
- Publication type:
- Article
Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 2, p. 224, doi. 10.1038/s41416-023-02493-7
- By:
- Publication type:
- Article